Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of telavancin on the intestinal microora of healthy subjects

Trial Profile

Effect of telavancin on the intestinal microora of healthy subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Telavancin (Primary)
  • Indications Bacteraemia; Bacterial infections; Nosocomial infections; Osteomyelitis; Skin and soft tissue infections
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 28 Jun 2017 New trial record
    • 05 Jun 2017 Results presented at the ASM Microbe 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top